Healthcare Market Research Reports
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Alpha-adrenoreceptor antagonists Alpha-adrenoreceptor antagonists and its peer markets - Proteomics, |
Upcoming |
|
|
Guanidine derivatives Guanidine derivatives and its peer markets - Immunoassay, |
Upcoming |
|
|
Thiazide derivatives Thiazide derivatives and its peer markets - Chromatography, |
Upcoming |
|
|
Hydrazinophthalazine derivatives Hydrazinophthalazine derivatives and its peer markets - Clinical Trial Management Systems (CTMS), |
Upcoming |
|
|
Pyrimidine derivatives Pyrimidine derivatives and its peer markets - Wireless Health, |
Upcoming |
|
|
Nitroferricyanide derivatives Nitroferricyanide derivatives and its peer markets - Immunoassay, |
Upcoming |
|
|
Pinacidil Pinacidil and its peer markets - Digital Pathology, |
Upcoming |
|
|
Alkaloids, excl. rauwolfia Alkaloids, excl. rauwolfia and its peer markets - Digital Pathology, |
Upcoming |
|
|
Tyrosine hydroxylase inhibitors Tyrosine hydroxylase inhibitors and its peer markets - Wireless Health, |
Upcoming |
|
|
MAO inhibitors MAO inhibitors and its peer markets - Serotonin antagonists, |
Upcoming |
|
|
Serotonin antagonists Serotonin antagonists and its peer markets - Proteomics, |
Upcoming |
|
|
Rauwolfia alkaloids and diuretics in combination Rauwolfia alkaloids and diuretics in combination and its peer markets - Proteomics, |
Upcoming |
|
|
Methyldopa and diuretics in combination Methyldopa and diuretics in combination and its peer markets - Hydrazinophthalazine derivatives and diuretics, |
Upcoming |
|
|
Imidazoline receptor agonists in combination with diuretics Imidazoline receptor agonists in combination with diuretics and its peer markets - Chromatography, |
Upcoming |
|
|
Alpha-adrenoreceptor antagonists and diuretics Alpha-adrenoreceptor antagonists and diuretics and its peer markets - Imidazoline receptor agonists in combination with... |
Upcoming |
|
|
Guanidine derivatives and diuretics Guanidine derivatives and diuretics and its peer markets - Chromatography Instruments, |
Upcoming |
|
|
Hydrazinophthalazine derivatives and diuretics Hydrazinophthalazine derivatives and diuretics and its peer markets - E-Clinical Trial Solutions, |
Upcoming |
|
|
Alkaloids, excl. rauwolfia, in combination with diuretics Alkaloids, excl. rauwolfia, in combination with diuretics and its peer markets - Methyldopa and diuretics in combination, |
Upcoming |
|
|
MAO inhibitors and diuretics MAO inhibitors and diuretics and its peer markets - Chromatography, |
Upcoming |
|
|
Serotonin antagonists and diuretics Serotonin antagonists and diuretics and its peer markets - Other antihypertensives and diuretics, |
Upcoming |
Healthcare
